About

iPSCs (induced pluripotent stem cells), an inexhaustible source of functional human cells, have enormous potential for biomedical research and health care. They are being used to study genetic disease, new drug development, and treatment of a broad range of disorders diabetes, cancer, neurological illnesses, and more. This forum explores uses of iPSCs for new strategies in preclinical and clinical applications.

Jesse McQuarters, Branded Content Editor at STAT

Ilyas Singe, M.D., Ph.D. Chief Scientific Officer, FUJIFILM Cellular Dynamics, Inc.

Ilyas was the inaugural director of the Stem Cell Translation Laboratory at NCATS/NIH, where he led the development of innovative technologies to help translate iPSC technology into clinical applications and drug discovery.

See original here:
New Opportunities for Human Stem Cells in Research and Clinical Applications - STAT